AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

SANTANDER UK PLC

Prospectus Aug 9, 2019

4587_prs_2019-08-09_273742a2-10d4-4439-b79e-5c96218ccc99.html

Prospectus

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6174I

Santander UK Group Holdings PLC

09 August 2019

SANTANDER UK GROUP HOLDINGS PLC

SANTANDER UK PLC

€30,000,000,000 EURO MEDIUM TERM NOTE PROGRAMME

PUBLICATION OF SUPPLEMENTARY PROSPECTUS

The following supplementary prospectus (the Supplementary Prospectus) has been approved by the UK Listing Authority and is available for viewing:

Supplementary Prospectus dated 9 August 2019 to the base prospectus dated 1 July 2019 as supplemented on 23 July 2019 relating to the €30,000,000,000 Euro Medium Term Note Programme of Santander UK Group Holdings plc and Santander UK plc (the Base Prospectus).

To view the full Supplementary Prospectus please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/6174I_1-2019-8-9.pdf

A copy of the Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM.

The Supplementary Prospectus will also be available for viewing via:

https://www.santander.co.uk/uk/about-santander-uk/investor-relations/euro-medium-term-note-programme 

For further information, please contact:

Medium Term Funding

Santander UK plc

2 Triton Square

Regent's Place

London NW1 3AN

Tel: +44 (0) 20 7756 7100

Email: [email protected]

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Supplementary Prospectus and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries only (as specified in the Base Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus you must ascertain from such Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

This publication of the Supplementary Prospectus does not constitute an offer of securities for sale in the United States. The securities described in the Base Prospectus have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold in the United States of America or to, or for the benefit of, U.S. persons (as defined in Regulation S of the Securities Act), unless the securities are registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

Your right to access this service is conditional upon your compliance with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

PSPEALPNELKNEFF

Talk to a Data Expert

Have a question? We'll get back to you promptly.